Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,121 USD | -2,97% | -13,75% | -64,06% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 17,64 mln. 16,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -15,93 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,37 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 13,25 mln. 12,42 mln. | Nettoliquiditeiten 2023 | 3,84 mln. 3,6 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,65
x | K/w-verhouding 2023 |
-1,53
x | Werknemers | 11 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 28,78% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | -2,97% | ||
1 week | -13,75% | ||
Lopende maand | -39,88% | ||
1 maand | -43,09% | ||
3 maanden | -61,07% | ||
6 maanden | -67,12% | ||
Lopend jaar | -64,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 28-03-22 |
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 1,121 | -2,97% | 7 933 |
16-04-24 | 1,156 | -3,71% | 14 524 |
15-04-24 | 1,2 | -0,83% | 9 109 |
12-04-24 | 1,21 | +10,00% | 28 156 |
11-04-24 | 1,1 | -15,38% | 37 351 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-64,06% | 8,88 mln. | |
-3,39% | 102 mld. | |
+2,61% | 96,84 mld. | |
-0,61% | 21,48 mld. | |
-18,14% | 20,82 mld. | |
-7,22% | 18,6 mld. | |
-40,70% | 16,81 mld. | |
-26,89% | 13,78 mld. | |
+1,12% | 13,4 mld. | |
+22,25% | 11,06 mld. |